Trump was treated with Regeneron’s experimental antibody therapy following his diagnosis with Covid-19 on Friday following a compassionate use request made by his doctors, which grants access in rare circumstances. The experimental therapy is unavailable to most Americans with fewer than 10 other people having been treated under compassionate use arrangements, a Regeneron spokesperson said. Trump has piled praise on Regeneron’s therapy in the days since his treatment, and called on regulators to approve Regeneron’s request for emergency authorization in a video Wednesday. TangentThis week Eli Lilly also requested emergency authorization from the FDA for its antibody therapy to treat Covid-19. Further ReadingAll The President’s Medicine (Forbes)What You Need To Know About Trump’s Experimental Coronavirus Antibody Treatment (Forbes)Regeneron CEO Says Trump Receiving Experimental Antibody Treatment Creates ‘Very Tough Situation’ (Forbes)Full coverage and live updates on the Coronavirus

Source: Forbes October 08, 2020 17:37 UTC